Time trends in the epidemiology of food allergy in England: an observational analysis of Clinical Practice Research Datalink data.

IF 25.4 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Lancet Public Health Pub Date : 2024-09-01 DOI:10.1016/S2468-2667(24)00163-4
Paul J Turner, Alessia Baseggio Conrado, Constantinos Kallis, Eimear O'Rourke, Sadia Haider, Anhar Ullah, Darije Custovic, Adnan Custovic, Jennifer K Quint
{"title":"Time trends in the epidemiology of food allergy in England: an observational analysis of Clinical Practice Research Datalink data.","authors":"Paul J Turner, Alessia Baseggio Conrado, Constantinos Kallis, Eimear O'Rourke, Sadia Haider, Anhar Ullah, Darije Custovic, Adnan Custovic, Jennifer K Quint","doi":"10.1016/S2468-2667(24)00163-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Estimates for the prevalence of food allergy vary widely, with a paucity of data for adults. The aim of this analysis was to report trends in the incidence and prevalence of food allergy in England, using a national primary care dataset.</p><p><strong>Methods: </strong>We analysed data from Clinical Practice Research Datalink between 1998 and 2018, with linked data to relevant hospital encounters in England. The main outcomes were incidence and prevalence of food allergy, according to three definitions of food allergy: possible food allergy, probable food allergy, and probable food allergy with adrenaline autoinjectors prescription. We also evaluated the difference in proportion of patients prescribed adrenaline autoinjectors by English Index of Multiple Deprivation (IMD), age, and by previous food anaphylaxis, and explored differences in patient encounters (general practice vs emergency department setting).</p><p><strong>Findings: </strong>7 627 607 individuals in the dataset were eligible for inclusion, of whom 150 018 (median age 19 years [IQR 4-34]; 82 614 [55·1%] female and 67 404 [44·9%] male) had a possible food allergy. 121 706 met diagnostic criteria for probable food allergy, of whom 38 288 were prescribed adrenaline autoinjectors. Estimated incidence of probable food allergy doubled between 2008 and 2018, from 75·8 individuals per 100 000 person-years (95% CI 73·7-77·9) in 2008 to 159·5 (156·6-162·3) individuals per 100 000 person-years in 2018. Prevalence increased from 0·4% (23 399 of 6 432 383) to 1·1% (82 262 of 7 627 607) over the same period and was highest in children under 5 years (11 951 [4·0%] of 296 406 in 2018) with lower prevalence in school-aged children (from 11 353 [2·4%] of 473 597 in 2018 for children aged 5-9 years to 6896 [1·7%] of 404 525 for those aged 15-19 years) and adults (42 848 [0·7%] of 5 992 454 in 2018). In those with previous food anaphylaxis, only 2321 (58·3%) of 3980 (975 [64·0%] of 1524 children and young people and 1346 [54·8%] of 2456 adults) had a prescription for adrenaline autoinjector. Adrenaline autoinjectors prescription was less common in those resident in more deprived areas (according to IMD). In the analysis of health-care encounters, 488 604 (97·1%) of 503 198 visits recorded for food allergy occurred in primary care, with 115 655 (88·4%) of 130 832 patients managed exclusively in primary care.</p><p><strong>Interpretation: </strong>These estimates indicate an important and increasing burden of food allergy in England. Our findings that most patients with food allergy are managed outside the hospital system, with low rates of adrenaline autoinjector prescription in those with previous anaphylaxis, highlight a need to better support those working in primary care to ensure optimal management of patients with food allergy.</p><p><strong>Funding: </strong>UK Food Standards Agency and UK Medical Research Council.</p>","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"9 9","pages":"e664-e673"},"PeriodicalIF":25.4000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Public Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/S2468-2667(24)00163-4","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Estimates for the prevalence of food allergy vary widely, with a paucity of data for adults. The aim of this analysis was to report trends in the incidence and prevalence of food allergy in England, using a national primary care dataset.

Methods: We analysed data from Clinical Practice Research Datalink between 1998 and 2018, with linked data to relevant hospital encounters in England. The main outcomes were incidence and prevalence of food allergy, according to three definitions of food allergy: possible food allergy, probable food allergy, and probable food allergy with adrenaline autoinjectors prescription. We also evaluated the difference in proportion of patients prescribed adrenaline autoinjectors by English Index of Multiple Deprivation (IMD), age, and by previous food anaphylaxis, and explored differences in patient encounters (general practice vs emergency department setting).

Findings: 7 627 607 individuals in the dataset were eligible for inclusion, of whom 150 018 (median age 19 years [IQR 4-34]; 82 614 [55·1%] female and 67 404 [44·9%] male) had a possible food allergy. 121 706 met diagnostic criteria for probable food allergy, of whom 38 288 were prescribed adrenaline autoinjectors. Estimated incidence of probable food allergy doubled between 2008 and 2018, from 75·8 individuals per 100 000 person-years (95% CI 73·7-77·9) in 2008 to 159·5 (156·6-162·3) individuals per 100 000 person-years in 2018. Prevalence increased from 0·4% (23 399 of 6 432 383) to 1·1% (82 262 of 7 627 607) over the same period and was highest in children under 5 years (11 951 [4·0%] of 296 406 in 2018) with lower prevalence in school-aged children (from 11 353 [2·4%] of 473 597 in 2018 for children aged 5-9 years to 6896 [1·7%] of 404 525 for those aged 15-19 years) and adults (42 848 [0·7%] of 5 992 454 in 2018). In those with previous food anaphylaxis, only 2321 (58·3%) of 3980 (975 [64·0%] of 1524 children and young people and 1346 [54·8%] of 2456 adults) had a prescription for adrenaline autoinjector. Adrenaline autoinjectors prescription was less common in those resident in more deprived areas (according to IMD). In the analysis of health-care encounters, 488 604 (97·1%) of 503 198 visits recorded for food allergy occurred in primary care, with 115 655 (88·4%) of 130 832 patients managed exclusively in primary care.

Interpretation: These estimates indicate an important and increasing burden of food allergy in England. Our findings that most patients with food allergy are managed outside the hospital system, with low rates of adrenaline autoinjector prescription in those with previous anaphylaxis, highlight a need to better support those working in primary care to ensure optimal management of patients with food allergy.

Funding: UK Food Standards Agency and UK Medical Research Council.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
英格兰食物过敏流行病学的时间趋势:临床实践研究数据链数据的观察分析。
背景:对食物过敏患病率的估计差异很大,成人的数据更是少之又少。本分析旨在利用全国初级保健数据集报告英格兰食物过敏发病率和流行率的趋势:我们分析了 1998 年至 2018 年期间临床实践研究数据链(Clinical Practice Research Datalink)中的数据,这些数据与英格兰相关医院的就诊情况相关联。主要结果是食物过敏的发生率和患病率,根据食物过敏的三种定义:可能的食物过敏、可能的食物过敏以及可能的食物过敏并伴有肾上腺素自动注射器处方。我们还根据英国多重贫困指数(IMD)、年龄和既往食物过敏性休克情况评估了开具肾上腺素自动注射器处方的患者比例差异,并探讨了患者就诊环境(全科诊所与急诊科)的差异:数据集中有 7 627 607 人符合纳入条件,其中 150 018 人(中位年龄 19 岁 [IQR:4-34];82 614 [55-1%] 女性和 67 404 [44-9%] 男性)可能患有食物过敏。121 706 人符合可能食物过敏的诊断标准,其中 38 288 人被处方肾上腺素自动注射器。2008 年至 2018 年期间,可能食物过敏的估计发病率翻了一番,从 2008 年的每 10 万人年 75-8 人(95% CI 73-7-77-9)增至 2018 年的每 10 万人年 159-5 人(156-6-162-3)。同期,患病率从 0-4%(6 432 383 例中的 23 399 例)上升至 1-1%(7 627 607 例中的 82 262 例),5 岁以下儿童患病率最高(2018 年为 296 406 例中的 11 951 例 [4-0%]),学龄儿童患病率较低(从 2008 年的 11 353 例 [95% CI 73-7-77-9] 上升至 2018 年的 296 406 例 [4-0%])。学龄儿童(从 2018 年 5-9 岁儿童的 473 597 例中的 11 353 例[2-4%]到 15-19 岁儿童的 404 525 例中的 6896 例[1-7%])和成人(2018 年 5 992 454 例中的 42 848 例[0-7%])的发病率较低。在曾发生食物过敏性休克的人群中,3980 人中只有 2321 人(58-3%)(1524 名儿童和青少年中的 975 人[64-0%]和 2456 名成人中的 1346 人[54-8%])有肾上腺素自动注射器处方。肾上腺素自动注射器处方在居住在较贫困地区(根据 IMD)的居民中较少见。在对就诊情况的分析中,503 198 例因食物过敏而就诊的记录中,有 488 604 例(97-1%)发生在初级医疗机构,130 832 例患者中有 115 655 例(88-4%)完全由初级医疗机构管理:这些估计数字表明,在英格兰,食物过敏是一个重要且日益加重的负担。我们的研究结果表明,大多数食物过敏患者都是在医院系统外接受治疗的,曾发生过敏性休克的患者使用肾上腺素自动注射器的比例很低,这突出表明有必要更好地支持基层医疗机构的工作,以确保对食物过敏患者进行最佳治疗:资金来源:英国食品标准局和英国医学研究委员会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Lancet Public Health
Lancet Public Health Medicine-Public Health, Environmental and Occupational Health
CiteScore
55.60
自引率
0.80%
发文量
305
审稿时长
8 weeks
期刊介绍: The Lancet Public Health is committed to tackling the most pressing issues across all aspects of public health. We have a strong commitment to using science to improve health equity and social justice. In line with the values and vision of The Lancet, we take a broad and inclusive approach to public health and are interested in interdisciplinary research. We publish a range of content types that can advance public health policies and outcomes. These include Articles, Review, Comment, and Correspondence. Learn more about the types of papers we publish.
期刊最新文献
Control of childhood obesity and implications for policy in China Public health interventions against childhood obesity in China Determinants of childhood obesity in China Obesity in China: what we know and what we can do Diabetes in China part 2: prevention, challenges, and progress
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1